TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
LinkoCare Life Sciences AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
189
|
1,052
|
0 |
Financial expenses |
13
|
33
|
9 |
Earnings before taxes |
-2,838
|
-1,104
|
-2,341 |
EBITDA |
-2,780
|
-972
|
-2,182 |
Total assets |
1,086
|
1,521
|
571 |
Current assets |
1,053
|
1,443
|
377 |
Current liabilities |
475
|
254
|
274 |
Equity capital |
611
|
1,267
|
297 |
- share capital |
34
|
33
|
36 |
Employees (average) |
4
![]() |
4
![]() |
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.3%
|
83.3%
|
52.0% |
Turnover per employee |
47
|
263
|
0 |
Profit as a percentage of turnover |
-1501.6%
|
-104.9% | |
Return on assets (ROA) |
-260.1%
|
-70.4%
|
-408.4% |
Current ratio |
221.7%
|
568.1%
|
137.6% |
Return on equity (ROE) |
-464.5%
|
-87.1%
|
-788.2% |
Change turnover |
-868
|
1,052
|
-7 |
Change turnover % | -82% | -100% | |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.